AEPCX
Price
$56.50
Change
-$0.76 (-1.33%)
Updated
Jun 13 closing price
Net Assets
132.56B
CWVIX
Price
$26.75
Change
-$0.53 (-1.94%)
Updated
Jun 13 closing price
Net Assets
898.03M
Interact to see
Advertisement

AEPCX vs CWVIX

Header iconAEPCX vs CWVIX Comparison
Open Charts AEPCX vs CWVIXBanner chart's image
American Funds EUPAC C
Price$56.50
Change-$0.76 (-1.33%)
VolumeN/A
Net Assets132.56B
Calvert International Equity I
Price$26.75
Change-$0.53 (-1.94%)
VolumeN/A
Net Assets898.03M
AEPCX vs CWVIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AEPCX vs. CWVIX commentary
Jun 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEPCX is a Buy and CWVIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
AEPCX has more cash in the bank: 133B vs. CWVIX (898M). CWVIX pays higher dividends than AEPCX: CWVIX (1.19) vs AEPCX (0.32). AEPCX was incepted earlier than CWVIX: AEPCX (24 years) vs CWVIX (26 years). AEPCX (1.59) is less costly to investors than CWVIX (0.95). AEPCX is a more actively managed with annual turnover of: 30.00 vs. CWVIX (23.00). AEPCX has a lower initial minimum investment than CWVIX: AEPCX (250) vs CWVIX (1000000). CWVIX annual gain was more profitable for investors over the last year : 7.59 vs. AEPCX (2.57). CWVIX return over 5 years is better than : 39.45 vs. AEPCX (14.79).
AEPCXCWVIXAEPCX / CWVIX
Total Expense Ratio1.590.89179%
Annual Report Gross Expense Ratio1.590.95167%
Fund Existence24 years26 years-
Gain YTD9.34812.06577%
Front LoadN/AN/A-
Min. Initial Investment25010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets133B898M14,811%
Annual Yield % from dividends0.321.1927%
Returns for 1 year2.577.5934%
Returns for 3 years23.3438.9560%
Returns for 5 years14.7939.4537%
Returns for 10 years16.8265.0226%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
BIS17.280.26
+1.53%
ProShares UltraShort Nasdaq Biotech
BTAL18.830.25
+1.35%
AGF U.S. Market Neutral Anti-Beta
EWZ28.14-0.01
-0.04%
iShares MSCI Brazil ETF
CHY10.48-0.15
-1.41%
Calamos Convertible and High Income Fund
IDGT79.70-1.48
-1.83%
iShares U.S. Digital Infras & RE ETF